Streetbeat News

MBTC

Nocturne Acquisition Corp

led by experienced technology and crypto operators, nocturne will leverage its deep industry expertise and vast global network to identify unique, public ready opportunities. our mission is to partner with a crypto or ai tech company that will enable the next frontier of innovation.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Peraso Inc. reported worse-than-expected Q4 EPS results, causing its shares to fall by over 23%. Other stocks experienced significant movements, with notable gainers including Ontrak, Fusion Pharmaceuticals, and Spire Global, among others. Losers included Greenwave Technology Solutions, Seelos Therapeutics, and Comtech Telecommunications, with various reasons such as disappointing financial results, downgrades, and restructuring of debt.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 5:48 pm

Nocturne Acquisition Corporation has announced its intention to extend the deadline for completing its initial business combination by one month to January 5, 2024, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 8:33 pm

Nocturne Acquisition Corp. and Cognos Therapeutics have secured Chardan as their capital markets advisor for their upcoming business combination. The role of Chardan will be to provide strategic advice and assist in the execution of the transaction.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 5:39 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.